3 Reasons CRISPR Stocks Could Keep Soaring – Motley Fool
|
3 Reasons CRISPR Stocks Could Keep Soaring
Motley Fool Billions are flowing into gene-editing biotechs even though everyone knows there’s a good chance none of these companies will ever earn a dime. Crispr Therapeutics AG (NASDAQ:CRSP), Editas Medicine Inc. (NASDAQ:EDIT), and Intellia Therapeutics Inc … |
Alzforum |
So Far, So Good for Parkinson’s Gene Therapy
Alzforum Using gene therapy to boost dopamine levels in the brain could soothe the symptoms of Parkinson’s disease, according to a March 9 press release. Voyager Therapeutics of Cambridge, Massachusetts, shared interim data from an ongoing, open-label Phase 1b … |
